Towards Sustainable Business Model Innovation for the Pharmaceutical Industry

This study examines pharmaceutical companies in the context of BMI. The purpose is to develop an SBM for the pharmaceutical industry and then to validate the causal relationships of the variables in such a business model. This study used purposive sampling by issuing questionnaires to 12 companies. The research consisted of the following four studies: Study 1: construction of dimension conceptualization. The conceptualization of BMI consists of three dimensions, i.e., technological, social, and organizational. Study 2 and study 3 are about process development and the construction of a unique BM. Study 2 explores the evolution of innovations in an SBM on the basis of a balance scorecard. Study 3 develops a unique SBM by referring to a focus group comprised of senior executives. Study 4: model validation. This stage is about the synthesis of research frameworks in the literature on BMI and an empirical study on the causal relationships in the context of SBMI.

Automated summary

This study examines pharmaceutical companies in the context of BMI, aiming to develop an SBM for the industry and validate the causal relationships of variables in such a business model. Through purposive sampling and questionnaire issuance to 12 companies, the research consists of four studies: construction of dimensional conceptualization, process development, unique BM construction, and model validation.